City State Bank’s Zevra Therapeutics ZVRA Stock Holding History

City State Bank’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$198K	Sell	13,798 -1,680	-11%	-$18.7K	0.05%	213
2026 Q1	$144K	Hold	15,478	–	–	0.04%	231
2025 Q4	$139K	Hold	15,478	–	–	0.04%	236
2025 Q3	$147K	Sell	15,478 -746	-5%	-$7.48K	0.04%	230
2025 Q2	$143K	Hold	16,224	–	–	0.04%	226
2025 Q1	$122K	Hold	16,224	–	–	0.04%	240
2024 Q4	$135K	Hold	16,224	–	–	0.05%	216
2024 Q3	$113K	Buy	16,224 +2,000	+14%	+$13.6K	0.04%	250
2024 Q2	$69.7K	Hold	14,224	–	–	0.03%	278
2024 Q1	$82K	Hold	14,224	–	–	0.04%	263
2023 Q4	$93K	Hold	14,224	–	–	0.05%	244
2023 Q3	$69K	Hold	14,224	–	–	0.04%	260
2023 Q2	$73K	Hold	14,224	–	–	0.04%	260
2023 Q1	$78K	Buy	14,224 +500	+4%	+$2.65K	0.04%	245
2022 Q4	$63K	Hold	13,724	–	–	0.04%	255
2022 Q3	$86K	Hold	13,724	–	–	0.06%	213
2022 Q2	$61K	Hold	13,724	–	–	0.04%	247
2022 Q1	$69K	Buy	13,724 +300	+2%	+$1.91K	0.04%	252
2021 Q4	$117K	Buy	+13,424	New	+$120K	0.07%	211

Other funds holding ZVRA

RPCONE

Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

IFG Advisors St. Louis, Missouri $725M AUM 27.52% 1-Year Est. Return

Element Squared Minneapolis, Minnesota $201M AUM 27.42% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

City State Bank's ZVRA Position: Q2 2026 in Review

City State Bank reduced its Zevra Therapeutics (ZVRA) stake by 11% in Q2 2026, selling an estimated $18.7K and leaving 13,798 shares worth $198K. The position accounts for 0.05% of the portfolio, ranked #213.

City State Bank first reported a position in ZVRA in Q4 2021 and has held it in 19 quarters since. 31 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

City State Bank held 13,798 shares of Zevra Therapeutics worth $198K as of Q2 2026.
City State Bank sold 1,680 Zevra Therapeutics shares in Q2 2026, an estimated $18.7K.
Zevra Therapeutics made up 0.05% of City State Bank's portfolio in Q2 2026, its #213 holding.
City State Bank first reported a position in Zevra Therapeutics in Q4 2021 and has held it in 19 quarters since.
31 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.